QNRX Stock Summary and Trading Ideas (Quoin Pharmaceuticals Ltd. - American Depositary Shares | NASDAQ:QNRX)

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Quoin Pharmaceuticals Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol QNRX.

As of January 23, 2026, QNRX stock price declined to $9.60 with 30,882 million shares trading.

QNRX has a beta of -1.45, meaning it tends to be less sensitive to market movements. QNRX has a correlation of 0.02 to the broad based SPY ETF.

QNRX has a market cap of $15.52 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, QNRX traded as high as $1,184.40 and as low as $5.01.

QNRX has underperformed the market in the last year with a price return of -33.3% while the SPY ETF gained +14.2%. QNRX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -28.4% and -21.4%, respectively, while the SPY returned +2.9% and -0.7%, respectively.

QNRX support price is $9.01 and resistance is $10.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that QNRX shares will trade within this expected range on the day.